| BioSpace
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, will collaborate to develop in vivo AAV-based therapies for up to eight central nervous system and…